Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

anaplastic oligodendroglioma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

anaplastic oligodendroglioma

MONDO:0016696

Also known as:WHO grade III oligodendroglial neoplasmWHO grade III oligodendroglial tumorWHO grade III oligodendroglial tumour

Find Clinical TrialsTrials

Overview

A WHO grade III oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).

Clinical Trials12 registered · 2 recruiting

Diagnosis

Biomarker and diagnostic research for anaplastic oligodendroglioma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

12 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE4, 2 PHASE2, 7 PHASE1. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT04541082](https://clinicaltrials.gov/study/NCT04541082)

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:05 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:251630

GARD

Genetic and Rare Diseases Info Center

GARD:9472

Questions for Your Care Team

→Are any of the 12 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Research summaries	41	26%
Laboratory research	35	22%
Testing and diagnosis research	29	19%
Disease patterns and progression	17	11%
Patient case studies	15	10%
Clinical study results	10	6%
Other research	5	3%
New treatment approaches	4	3%

anaplastic oligodendroglioma

Overview

Diagnosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications